SciNeuro

Rockville, United States

SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.

$53.0M raised

Dec 2025

Venture - Series Unknown

Top Investors

HSGGeneral AtlanticARCH Venture PartnersLilly Asia VenturesBoyu Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SciNeuro raised?

SciNeuro has raised $53.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.

Who are SciNeuro's investors?

SciNeuro's investors include HSG, General Atlantic, ARCH Venture Partners, Lilly Asia Ventures, Boyu Capital.

Where is SciNeuro headquartered?

SciNeuro is headquartered in Rockville, United States.

What does SciNeuro do?

SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.

What stage is SciNeuro at?

SciNeuro is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2025.

MLA

"SciNeuro — Funding & Investors." VCBacked, December 4, 2025, https://www.vcbacked.co/company/scineuro. Accessed June 4, 2026.

APA

VCBacked. (2025). SciNeuro — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/scineuro

Wikipedia (cite web)

{{cite web |title=SciNeuro — Funding & Investors |url=https://www.vcbacked.co/company/scineuro |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2025.